Alles Mark J Insider Trades

Insider Trading History

Track insider trading activity for Alles Mark J. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $1.07 5,334 shares
Last Trade
Sep 16, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.5k 2,666 shares
$3.93
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $0.733 3,666 shares
Last Trade
Sep 16, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.5k 2,666 shares
$3.93
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $1.2 6,000 shares
Last Trade
Jun 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.2k 6,000 shares
$3.70
$0.00
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Director
Holding Value $825k 15,095 shares
Last Trade
May 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$385k 4,190 shares
$91.99
$54.66
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Director
Holding Value $596k 10,905 shares
Last Trade
Oct 31, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$314k 3,625 shares
$86.75
$54.66
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $2.4 12,000 shares
Last Trade
Sep 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.7k 20,000 shares
$0.73
$0.00
Turning Point Therapeutics
Turning Point Therapeutics TPTX
Director
Holding Value $0 0 shares
Last Trade
Aug 17, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$15.9k 209 shares
$76.01
$75.49
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $3.5 17,500 shares
Last Trade
Jun 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.7k 17,500 shares
$0.78
$0.00
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Director
Holding Value $398k 7,280 shares
Last Trade
May 24, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$392k 4,980 shares
$78.78
$54.66
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Director
Holding Value $126k 2,300 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$206k 2,300 shares
$89.36
$54.66
Turning Point Therapeutics
Turning Point Therapeutics TPTX
Director
Holding Value $151k 2,000 shares
Last Trade
Jun 21, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$163k 2,000 shares
$81.34
$75.49
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $3.5 17,500 shares
Last Trade
Jun 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$110k 17,500 shares
$6.30
$0.00
Turning Point Therapeutics
Turning Point Therapeutics TPTX
Director
Holding Value $15.8k 209 shares
Last Trade
Jun 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.7k 209 shares
$65.64
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
Director
Holding Value $1.28M 17,000 shares
Last Trade
May 24, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.2M 17,000 shares
$70.60
$75.49
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $3.5 17,500 shares
Last Trade
Jun 11, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$160k 17,500 shares
$9.17
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $2 10,000 shares
Last Trade
May 13, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$88.6k 10,000 shares
$8.86
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $7 35,000 shares
Last Trade
Dec 19, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$218k 35,000 shares
$6.22
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up